You watched
Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
3
Wishlist
0
Compare
0
Contacts

Levofloxacin-Novopharm solution for infusion 5 mg/ml bottle 100 ml No. 1

SKU: an-1049591
0
All about product
Description
Specification
Reviews 0
Questions0
new
Levofloxacin-Novopharm solution for infusion 5 mg/ml bottle 100 ml No. 1
Levofloxacin-Novopharm solution for infusion 5 mg/ml bottle 100 ml No. 1
Levofloxacin-Novopharm solution for infusion 5 mg/ml bottle 100 ml No. 1
Levofloxacin-Novopharm solution for infusion 5 mg/ml bottle 100 ml No. 1
In Stock
318.72 грн.
Buy this product in 1 click:
Active ingredient:Levofloxacin
Adults:Can
ATC code:J ANTIMIBRICANTS FOR SYSTEMIC USE; J01 ANTIBACTERIALS FOR SYSTEMIC USE; J01M ANTIBACTERIALS FROM THE QUINOLON GROUP; J01M A Fluoroquinolones; J01M A12 Levofloxacin
Country of manufacture:Ukraine
Diabetics:With caution
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Levofloxacin-Novopharm solution for infusion 5 mg/ml bottle 100 ml No. 1
318.72 грн.
Description

Levofloxacin-Novopharm solution for infusion is indicated for infections caused by sensitive microorganisms:

acute bacterial rhinosinusitis; exacerbation of chronic obstructive pulmonary disease, including bronchitis; community-acquired pneumonia; complicated skin and soft tissue infections; uncomplicated cystitis; acute pyelonephritis and complicated urinary tract infections; chronic bacterial prostatitis; pulmonary anthrax: post-exposure prophylaxis and treatment.

Composition

Active ingredient: levofloxacin hemihydrate;

1 ml of levofloxacin hemihydrate equivalent to levofloxacin 5 mg;

Excipients: sodium chloride, sodium hydroxide, concentrated hydrochloric acid, water for injections.

Contraindication

Hypersensitivity to levofloxacin, other quinolones, or any component of the drug.

Adverse reactions from tendons after previous use of quinolones.

Epilepsy. Age under 18 years. Pregnancy and breastfeeding.

Method of application

The drug is administered intravenously slowly 1 or 2 times a day. The dosage depends on the type and severity of the infection, as well as the sensitivity of the possible pathogen to the drug. Treatment with levofloxacin after the first use of its intravenous form can be completed by using the oral form, provided that such treatment is acceptable for the individual patient. Given the bioequivalence of parenteral and oral dosage forms, the same dose can be used.

Application features

Pregnant women

The drug is contraindicated during pregnancy or breastfeeding. If pregnancy is diagnosed during treatment, the doctor should be informed.

Children

The use of the drug is contraindicated in children (under 18 years of age), as damage to articular cartilage cannot be ruled out.

Drivers

Patients who drive vehicles, work with machines and mechanisms should take into account possible adverse reactions from the nervous system (dizziness, drowsiness, confusion, visual and hearing impairment, movement disorders, including while walking).

Overdose

The most important expected symptoms of overdose concern the central nervous system (dizziness, impaired consciousness and convulsions); gastrointestinal reactions such as nausea and erosion of the mucous membranes. When using doses exceeding therapeutic, there is a prolongation of the QT interval. In case of overdose, careful monitoring of the patient, including ECG, is necessary.

Side effects

Infections and infestations. Uncommon: fungal infections, including Candida infections. Resistance of pathogenic microorganisms. Psychiatric disorders. Common: insomnia. Uncommon: anxiety, confusion, nervousness. Nervous system disorders. Common: headache, dizziness. Vascular disorders. Common: phlebitis (only for intravenous forms of administration). Hepatobiliary disorders. Common: increased activity of liver enzymes (ALT/AST, alkaline phosphatase, GGT). General disorders and administration site conditions. Common: infusion site reaction (pain, redness).

Interaction

Clinical pharmacology studies have demonstrated that no clinically significant effect on the pharmacokinetics of levofloxacin was caused when levofloxacin was used together with the following drugs: calcium carbonate, digoxin, glibenclamide, ranitidine.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 2 years.

Specifications
Characteristics
Active ingredient
Levofloxacin
Adults
Can
ATC code
J ANTIMIBRICANTS FOR SYSTEMIC USE; J01 ANTIBACTERIALS FOR SYSTEMIC USE; J01M ANTIBACTERIALS FROM THE QUINOLON GROUP; J01M A Fluoroquinolones; J01M A12 Levofloxacin
Country of manufacture
Ukraine
Diabetics
With caution
Dosage
5 mg/ml
Drivers
It is impossible.
For allergies
With caution
For children
It is impossible.
Form
Infusions
Method of application
Injections
Nursing
It is impossible.
Pregnant
It is impossible.
Producer
Novopharm-Biosynthes LLC
Quantity per package
100 ml
Trade name
Levofloxacin
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Ginipral solution for injection 10 mcg ampoule 2 ml No. 5
In stock
0
385.60 грн.
new
new
Cefix powder for oral suspension 100 mg/5 ml bottle 30 ml
In stock
0
322.90 грн.
318.72 грн.